Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has entered into a collaboration agreement with a new partner to develop Cadmium Zinc Telluride (“CZT”) based detectors for photon counting computed tomography applications in the medical imaging sector.
The new blue-chip partner is a technology solutions provider to over 100,000 customers globally for a range of applications, including healthcare.
As part of the collaboration, Kromek will integrate its CZT sensors with the partner’s read-out electronics to ensure optimal computed tomography (“CT”) detection system performance. As the project progresses towards commercialisation, the Group will ensure production capability is available to support commercial demand ramp-up.
Arnab Basu, CEO of Kromek, said: “At Kromek, we have a strong track record of teaming up with leading global technology partners to advance new imaging solutions. Our CZT-based products are the enabling technology in ultra high-resolution systems. These systems provide clinicians with greater image quality that leads to earlier diagnosis, better patient outcomes and ultimately saves lives. We look forward to working with this new blue-chip partner to make another important advancement in medical imaging technology.”